# Everest Life Sciences LLC – FDA Inspection, Apr 23, 2025

Source: https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/c8c57801-5139-4351-b5c2-5a1ba452bda1
Source feed: FDA_Inspections

> FDA inspection 1267697 of Everest Life Sciences LLC, April 23, 2025. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267697
- Company Name: Everest Life Sciences LLC
- Inspection Date: 2025-04-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1071273 - 2018-10-23](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/1c8d7013-fd1a-4c29-a267-fbd6fd8e92b6)
- FDA Inspection 1063269 - 2018-07-13
- FDA Inspection 964002 - 2016-03-16
- FDA Inspection 778012 - 2012-04-16
- FDA Inspection 710185 - 2011-02-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jessica-s-estriplet/b7152ec3-6e1b-45aa-840e-7147f357aea2)
- [Investigator](https://www.keypedia.com/people/suchan-kim/1acf9a36-036f-48a8-a8a4-caa290830e37)

Company: https://www.keypedia.com/companies/everest-life-sciences-llc/3f0de21d-b48b-4f8a-a8a2-3b6e376528f4

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248